Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$209.01 - $232.56 $497,234 - $553,260
2,379 New
2,379 $519,000
Q2 2022

Aug 11, 2022

SELL
$213.86 - $277.87 $3.03 Million - $3.94 Million
-14,188 Reduced 84.18%
2,666 $625,000
Q1 2022

May 13, 2022

BUY
$259.82 - $298.18 $3.22 Million - $3.7 Million
12,410 Added 279.25%
16,854 $4.44 Million
Q4 2021

Feb 14, 2022

SELL
$271.6 - $314.21 $2.23 Million - $2.59 Million
-8,229 Reduced 64.93%
4,444 $1.4 Million
Q3 2021

Nov 12, 2021

BUY
$274.82 - $308.34 $1.36 Million - $1.53 Million
4,960 Added 64.31%
12,673 $3.57 Million
Q2 2021

Aug 12, 2021

BUY
$251.87 - $278.14 $1.94 Million - $2.15 Million
7,713 New
7,713 $2.13 Million
Q3 2020

Nov 06, 2020

SELL
$167.03 - $201.3 $2.93 Million - $3.54 Million
-17,569 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$113.31 - $182.44 $444,401 - $715,529
3,922 Added 28.74%
17,569 $2.92 Million
Q1 2020

May 08, 2020

SELL
$104.32 - $195.28 $1.26 Million - $2.36 Million
-12,077 Reduced 46.95%
13,647 $1.73 Million
Q4 2019

Feb 12, 2020

BUY
$163.48 - $173.61 $4.21 Million - $4.47 Million
25,724 New
25,724 $4.35 Million
Q1 2019

May 13, 2019

SELL
$123.7 - $156.3 $2.42 Million - $3.06 Million
-19,582 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$120.82 - $174.09 $2.37 Million - $3.41 Million
19,582 New
19,582 $2.47 Million
Q2 2018

Aug 07, 2018

SELL
$160.33 - $189.41 $1.34 Million - $1.59 Million
-8,386 Closed
0 $0
Q1 2018

May 03, 2018

BUY
$161.53 - $178.11 $1.35 Million - $1.49 Million
8,386 New
8,386 $1.36 Million
Q4 2017

Feb 09, 2018

SELL
$147.99 - $163.95 $348,960 - $386,594
-2,358 Closed
0 $0
Q3 2017

Nov 09, 2017

BUY
$149.47 - $160.56 $352,450 - $378,600
2,358
2,358 $356,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.